Clinical Trial Update: Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct [Phase 2]

View source ↗

Summary

Phase 2 trial update examining intravenous autologous mesenchymal stem cell transplantation for middle cerebral artery infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle Cerebral Artery Infarction
• Stroke

Drugs mentioned

• Autologous mesenchymal stem cell transplantation (Mesenchymal stem cells)

Snippet

Sponsor: National University of Malaysia | Conditions: Middle Cerebral Artery Infarction | Phase 2 | Status: UNKNOWN